Cargando…

Infertility treatment for Chinese women with P450 oxidoreductase deficiency: Prospect on clinical management from IVF to FET

Cytochrome P450 oxidoreductase deficiency (PORD) is a rare recessive disease with multiple clinical manifestations, which is usually diagnosed in neonates and children because of ambiguous genitalia or skeletal malformations. Moreover, the paucity of studies does not allow us to establish whether ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Zhang, Cui-Lian, Zhang, Shao-Di
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813486/
https://www.ncbi.nlm.nih.gov/pubmed/36619579
http://dx.doi.org/10.3389/fendo.2022.1019696
_version_ 1784863931741765632
author Li, Yan
Zhang, Cui-Lian
Zhang, Shao-Di
author_facet Li, Yan
Zhang, Cui-Lian
Zhang, Shao-Di
author_sort Li, Yan
collection PubMed
description Cytochrome P450 oxidoreductase deficiency (PORD) is a rare recessive disease with multiple clinical manifestations, which is usually diagnosed in neonates and children because of ambiguous genitalia or skeletal malformations. Moreover, the paucity of studies does not allow us to establish whether adult-onset PORD is associated with infertility. Here, we report clinical and laboratory findings in two phenotypically normal women diagnosed with PORD who underwent in vitro fertilization (IVF) and frozen embryo transfer (FET). We modified the gonadotropin stimulation protocol during controlled ovarian hyperstimulation (COH) and suggest the use of the vaginal 17β-estradiol route for endometrium preparation in hormone replacement therapy (HRT) cycles. We presume that PORD may be associated with infertility in several aspects, including disordered steroidogenesis, endometrium impairment, attenuation of drug metabolism, and the high risk of miscarriage. Our observations will help the early diagnosis and make a tailored approach to infertility management in adult-onset PORD.
format Online
Article
Text
id pubmed-9813486
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98134862023-01-06 Infertility treatment for Chinese women with P450 oxidoreductase deficiency: Prospect on clinical management from IVF to FET Li, Yan Zhang, Cui-Lian Zhang, Shao-Di Front Endocrinol (Lausanne) Endocrinology Cytochrome P450 oxidoreductase deficiency (PORD) is a rare recessive disease with multiple clinical manifestations, which is usually diagnosed in neonates and children because of ambiguous genitalia or skeletal malformations. Moreover, the paucity of studies does not allow us to establish whether adult-onset PORD is associated with infertility. Here, we report clinical and laboratory findings in two phenotypically normal women diagnosed with PORD who underwent in vitro fertilization (IVF) and frozen embryo transfer (FET). We modified the gonadotropin stimulation protocol during controlled ovarian hyperstimulation (COH) and suggest the use of the vaginal 17β-estradiol route for endometrium preparation in hormone replacement therapy (HRT) cycles. We presume that PORD may be associated with infertility in several aspects, including disordered steroidogenesis, endometrium impairment, attenuation of drug metabolism, and the high risk of miscarriage. Our observations will help the early diagnosis and make a tailored approach to infertility management in adult-onset PORD. Frontiers Media S.A. 2022-12-22 /pmc/articles/PMC9813486/ /pubmed/36619579 http://dx.doi.org/10.3389/fendo.2022.1019696 Text en Copyright © 2022 Li, Zhang and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Li, Yan
Zhang, Cui-Lian
Zhang, Shao-Di
Infertility treatment for Chinese women with P450 oxidoreductase deficiency: Prospect on clinical management from IVF to FET
title Infertility treatment for Chinese women with P450 oxidoreductase deficiency: Prospect on clinical management from IVF to FET
title_full Infertility treatment for Chinese women with P450 oxidoreductase deficiency: Prospect on clinical management from IVF to FET
title_fullStr Infertility treatment for Chinese women with P450 oxidoreductase deficiency: Prospect on clinical management from IVF to FET
title_full_unstemmed Infertility treatment for Chinese women with P450 oxidoreductase deficiency: Prospect on clinical management from IVF to FET
title_short Infertility treatment for Chinese women with P450 oxidoreductase deficiency: Prospect on clinical management from IVF to FET
title_sort infertility treatment for chinese women with p450 oxidoreductase deficiency: prospect on clinical management from ivf to fet
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813486/
https://www.ncbi.nlm.nih.gov/pubmed/36619579
http://dx.doi.org/10.3389/fendo.2022.1019696
work_keys_str_mv AT liyan infertilitytreatmentforchinesewomenwithp450oxidoreductasedeficiencyprospectonclinicalmanagementfromivftofet
AT zhangcuilian infertilitytreatmentforchinesewomenwithp450oxidoreductasedeficiencyprospectonclinicalmanagementfromivftofet
AT zhangshaodi infertilitytreatmentforchinesewomenwithp450oxidoreductasedeficiencyprospectonclinicalmanagementfromivftofet